📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sanifit

1.1 - Company Overview

Sanifit Logo

Sanifit

Headquarter: Spain
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology therapies for calcification disorders, developing SNF472 in phase 3 for calciphylaxis associated with chronic kidney disease and dialysis, and for peripheral artery disease in end-stage kidney disease, aiming to reduce arterial and cardiovascular calcification; supported by the CaLIPSO phase 2b trial showing significant reduction in coronary artery calcium progression in dialysis patients.

Products and services

  • CaLIPSO study: Phase 2b–validated clinical assessment that quantified SNF472’s ability to slow arterial calcification in dialysis patients, demonstrating significant reduction in coronary artery calcium progression
  • SNF472 for calciphylaxis: Phase 3 investigational therapy engineered to block cardiovascular calcification progression in a rare disease linked to chronic kidney disease and dialysis
  • SNF472 for peripheral artery disease in end-stage kidney disease: Phase 3 clinical-stage agent created to reduce arterial calcification in ESKD patients with PAD

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sanifit

Vesper Medical Logo

Vesper Medical

HQ: United States Website
  • Description: Provider of venous stenting solutions for deep venous disease, centered on the purpose-built Vesper DUO Venous Stent System, a portfolio of self-expanding nitinol stents to improve luminal diameter in symptomatic venous outflow obstructions, including DUO-HYBRID and DUO-EXTEND, and the VIVID clinical trial evaluating safety and efficacy in iliofemoral occlusive disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vesper Medical company profile →
Tarilian Laser Technologies Logo

Tarilian Laser Technologies

HQ: United Kingdom Website
  • Description: Provider of medical technology pioneering an innovative breakthrough in blood pressure monitoring through an unobtrusive wrist-worn wearable device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tarilian Laser Technologies company profile →
Renovacor Logo

Renovacor

HQ: United States Website
  • Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renovacor company profile →
Action Pharma Logo

Action Pharma

HQ: Denmark Website
  • Description: Provider of R&D-focused drug discovery and development, creating pharmaceutical products and treatment concepts for cardiovascular and inflammatory diseases and acquired metabolic diseases, including type-II diabetes and obesity; product pipeline includes AP214.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Action Pharma company profile →
VNUS Logo

VNUS

HQ: United States Website
  • Description: Provider of products and minimally invasive treatments for venous diseases, including the patented Closure System for patients with symptoms associated with venous reflux; a world leader in the development and marketing of minimally invasive treatments for venous diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VNUS company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sanifit

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sanifit

2.2 - Growth funds investing in similar companies to Sanifit

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sanifit

4.2 - Public trading comparable groups for Sanifit

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sanifit

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sanifit

What does Sanifit do?

Sanifit is a provider of biotechnology therapies for calcification disorders, developing SNF472 in phase 3 for calciphylaxis associated with chronic kidney disease and dialysis, and for peripheral artery disease in end-stage kidney disease, aiming to reduce arterial and cardiovascular calcification; supported by the CaLIPSO phase 2b trial showing significant reduction in coronary artery calcium progression in dialysis patients.

Who are Sanifit's competitors?

Sanifit's competitors and similar companies include Vesper Medical, Tarilian Laser Technologies, Renovacor, Action Pharma, and VNUS.

Where is Sanifit headquartered?

Sanifit is headquartered in Spain.

How many employees does Sanifit have?

Sanifit has 1,000 employees 🔒.

When was Sanifit founded?

Sanifit was founded in 2010 🔒.

What sector and industry vertical is Sanifit in?

Sanifit is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sanifit

Who are the top strategic acquirers in Sanifit's sector and industry

Top strategic M&A buyers and acquirers in Sanifit's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sanifit?

Top strategic M&A buyers groups and sectors for Sanifit include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sanifit's sector and industry vertical

Which are the top PE firms investing in Sanifit's sector and industry vertical?

Top PE firms investing in Sanifit's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sanifit's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sanifit's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sanifit's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sanifit include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sanifit's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sanifit?

The key public trading comparables and valuation benchmarks for Sanifit include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sanifit for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sanifit with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sanifit's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sanifit with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sanifit's' sector and industry vertical?

Access recent funding rounds and capital raises in Sanifit's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sanifit

Launch login modal Launch register modal